MIRM
Mirum Pharmaceuticals, Inc.$99.47-0.07 (-0.07%)Prev Close$99.54·MCap$5.00B·P/E—·Vol409.9K·Yield—
▲
Buys (12M)
1
$9.00M
▼
Sells (12M)
38
$35.25M
◆
Net Activity
Net Seller
$26.25M
●
Active Insiders
10
last 12 mo
Over the past 12 months, insider activity at Mirum Pharmaceuticals, Inc. (MIRM) has been dominated by selling, with 1 insider purchase totaling $9.00M and 38 insider sales totaling $35.25M. The most recent insider transaction was by BJERKHOLT ERIC (officer: CHIEF FINANCIAL OFFICER), who sold $469.1K worth of shares on Jun 9, 2026. Mirum Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $5.00B.
MIRM Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | Sell | 5,000 | $93.82 | $469.1K | 47,530 |
| Jun 2, 2026 | Ramasastry Saira | director | Sell | 3,977 | $100.00 | $397.7K | 0Exit |
| Jun 2, 2026 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 30,000 | $95.84 | $2.88M | 221,707 |
| May 18, 2026 | Ramasastry Saira | director | Sell | 2,000 | $109.47 | $218.9K | 0Exit |
| Apr 16, 2026 | Ramasastry Saira | director | Sell | 2,000 | $96.90 | $193.8K | 0Exit |
| Mar 17, 2026 | Ramasastry Saira | director | Sell | 2,000 | $90.76 | $181.5K | 0Exit |
| Mar 17, 2026 | Quan Joanne | officer: CHIEF MEDICAL OFFICER | Sell | 7,287 | $91.98 | $670.2K | 18,864-28% |
| Mar 17, 2026 | Radovich Peter | officer: PRESIDENT AND COO | Sell | 16,515 | $91.98 | $1.52M | 40,272-29% |
| Mar 17, 2026 | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | Sell | 7,287 | $91.98 | $670.2K | 49,788 |
| Mar 17, 2026 | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | Sell | 4,732 | $91.98 | $435.2K | 8,429-36% |
| Mar 17, 2026 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 40,985 | $91.98 | $3.77M | 194,309 |
| Feb 13, 2026 | Ramasastry Saira | Director | Sell | 2,000 | $102.09 | $204.2K | 0 |
| Feb 3, 2026 | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | Sell | 968 | $103.30 | $100.0K | 4,503 |
| Feb 3, 2026 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 9,108 | $103.30 | $940.9K | 160,294 |
| Feb 3, 2026 | Radovich Peter | officer: PRESIDENT AND COO | Sell | 2,631 | $103.30 | $271.8K | 20,655 |
| Jan 27, 2026 | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | Sell | 1,053 | $96.19 | $101.3K | 43,741 |
| Jan 27, 2026 | Heron Patrick J | director | Buy | 131,425 | $68.48 | $9.00M | 459,010+40% |
| Jan 27, 2026 | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | Sell | 842 | $96.19 | $81.0K | 3,700 |
| Jan 27, 2026 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 6,831 | $96.19 | $657.1K | 169,402 |
| Jan 27, 2026 | Radovich Peter | officer: PRESIDENT AND COO | Sell | 3,143 | $96.19 | $302.3K | 23,286 |
| Jan 23, 2026 | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | Sell | 1,421 | $93.33 | $132.6K | 42,127 |
| Jan 23, 2026 | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | Sell | 926 | $93.33 | $86.4K | 3,042 |
| Jan 23, 2026 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 7,098 | $93.33 | $662.4K | 163,733 |
| Jan 23, 2026 | Quan Joanne | officer: CHIEF MEDICAL OFFICER | Sell | 1,822 | $93.33 | $170.0K | 12,817 |
| Jan 23, 2026 | Radovich Peter | officer: PRESIDENT AND COO | Sell | 2,382 | $93.33 | $222.3K | 20,679 |
| Jan 21, 2026 | Quan Joanne | officer: CHIEF MEDICAL OFFICER | Sell | 6,911 | $90.27 | $623.9K | 11,305-38% |
| Jan 16, 2026 | Ramasastry Saira | director | Sell | 2,000 | $90.99 | $182.0K | 0Exit |
| Dec 23, 2025 | GREY MICHAEL G | Sell | 50,000 | $78.00 | $3.90M | 0Exit | |
| Dec 23, 2025 | Ramasastry Saira | Sell | 5,000 | $80.00 | $400.0K | 0Exit | |
| Dec 19, 2025 | Ramasastry Saira | Sell | 2,000 | $69.73 | $139.5K | 1,000-67% | |
| Dec 2, 2025 | GREY MICHAEL G | Sell | 50,000 | $74.00 | $3.70M | 0Exit | |
| Nov 25, 2025 | GREY MICHAEL G | Sell | 50,000 | $70.00 | $3.50M | 0Exit | |
| Sep 12, 2025 | Brege Laura | Sell | 17,000 | $74.40 | $1.26M | 17,194-50% | |
| Sep 12, 2025 | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | Sell | 9,578 | $76.01 | $728.0K | 39,945 |
| Aug 12, 2025 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 40,000 | $62.00 | $2.48M | 138,641 |
| Aug 8, 2025 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 10,000 | $58.00 | $580.0K | 2,426-80% |
| Aug 8, 2025 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 40,000 | $55.25 | $2.21M | 138,641 |
| Jul 3, 2025 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 1,041 | $48.63 | $50.6K | 2,903-26% |
| Jun 13, 2025 | Fairey William | Sell | 3,203 | $48.42 | $155.1K | 2,500-56% | |
| Jun 4, 2025 | Ramasastry Saira | Sell | 8,203 | $46.06 | $377.8K | 0Exit | |
| Mar 19, 2025 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 2,415 | $44.45 | $107.3K | 2,426-50% |
| Mar 18, 2025 | Heron Patrick J | Buy | 549 | $44.11 | $24.2K | 168,672 | |
| Mar 18, 2025 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 57,606 | $44.35 | $2.55M | 9,436-86% |
| Mar 18, 2025 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 27,279 | $44.21 | $1.21M | 138,641 |
| Mar 18, 2025 | Radovich Peter | PRESIDENT AND COO | Sell | 7,879 | $44.21 | $348.4K | 18,672-30% |
| Mar 12, 2025 | Heron Patrick J | Buy | 2,298 | $43.31 | $99.5K | 168,123 | |
| Mar 10, 2025 | Heron Patrick J | Buy | 1,915 | $43.69 | $83.7K | 165,825 | |
| Mar 6, 2025 | Heron Patrick J | Buy | 1,602 | $45.40 | $72.7K | 163,910 | |
| Mar 5, 2025 | Radovich Peter | PRESIDENT AND COO | Sell | 14,850 | $45.58 | $676.9K | 13,280-53% |
| Mar 4, 2025 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 40,000 | $46.91 | $1.88M | 136,528 |
Showing 1–50 of 110
1 / 3
MIRM Insider Buying Activity
The following table shows recent insider purchases of Mirum Pharmaceuticals, Inc. (MIRM) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | Heron Patrick J | director | Buy | 131,425 | $68.48 | $9.00M | 459,010+40% |
| Mar 18, 2025 | Heron Patrick J | Buy | 549 | $44.11 | $24.2K | 168,672 | |
| Mar 12, 2025 | Heron Patrick J | Buy | 2,298 | $43.31 | $99.5K | 168,123 | |
| Mar 10, 2025 | Heron Patrick J | Buy | 1,915 | $43.69 | $83.7K | 165,825 | |
| Mar 6, 2025 | Heron Patrick J | Buy | 1,602 | $45.40 | $72.7K | 163,910 |
MIRM Insider Selling Activity
The following table shows recent insider sales of Mirum Pharmaceuticals, Inc. (MIRM) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | Sell | 5,000 | $93.82 | $469.1K | 47,530 |
| Jun 2, 2026 | Ramasastry Saira | director | Sell | 3,977 | $100.00 | $397.7K | 0Exit |
| Jun 2, 2026 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 30,000 | $95.84 | $2.88M | 221,707 |
| May 18, 2026 | Ramasastry Saira | director | Sell | 2,000 | $109.47 | $218.9K | 0Exit |
| Apr 16, 2026 | Ramasastry Saira | director | Sell | 2,000 | $96.90 | $193.8K | 0Exit |
| Mar 17, 2026 | Ramasastry Saira | director | Sell | 2,000 | $90.76 | $181.5K | 0Exit |
| Mar 17, 2026 | Quan Joanne | officer: CHIEF MEDICAL OFFICER | Sell | 7,287 | $91.98 | $670.2K | 18,864-28% |
| Mar 17, 2026 | Radovich Peter | officer: PRESIDENT AND COO | Sell | 16,515 | $91.98 | $1.52M | 40,272-29% |
| Mar 17, 2026 | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | Sell | 7,287 | $91.98 | $670.2K | 49,788 |
| Mar 17, 2026 | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | Sell | 4,732 | $91.98 | $435.2K | 8,429-36% |
| Mar 17, 2026 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 40,985 | $91.98 | $3.77M | 194,309 |
| Feb 13, 2026 | Ramasastry Saira | Director | Sell | 2,000 | $102.09 | $204.2K | 0 |
| Feb 3, 2026 | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | Sell | 968 | $103.30 | $100.0K | 4,503 |
| Feb 3, 2026 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 9,108 | $103.30 | $940.9K | 160,294 |
| Feb 3, 2026 | Radovich Peter | officer: PRESIDENT AND COO | Sell | 2,631 | $103.30 | $271.8K | 20,655 |
| Jan 27, 2026 | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | Sell | 1,053 | $96.19 | $101.3K | 43,741 |
| Jan 27, 2026 | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | Sell | 842 | $96.19 | $81.0K | 3,700 |
| Jan 27, 2026 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 6,831 | $96.19 | $657.1K | 169,402 |
| Jan 27, 2026 | Radovich Peter | officer: PRESIDENT AND COO | Sell | 3,143 | $96.19 | $302.3K | 23,286 |
| Jan 23, 2026 | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | Sell | 1,421 | $93.33 | $132.6K | 42,127 |
| Jan 23, 2026 | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | Sell | 926 | $93.33 | $86.4K | 3,042 |
| Jan 23, 2026 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 7,098 | $93.33 | $662.4K | 163,733 |
| Jan 23, 2026 | Quan Joanne | officer: CHIEF MEDICAL OFFICER | Sell | 1,822 | $93.33 | $170.0K | 12,817 |
| Jan 23, 2026 | Radovich Peter | officer: PRESIDENT AND COO | Sell | 2,382 | $93.33 | $222.3K | 20,679 |
| Jan 21, 2026 | Quan Joanne | officer: CHIEF MEDICAL OFFICER | Sell | 6,911 | $90.27 | $623.9K | 11,305-38% |
| Jan 16, 2026 | Ramasastry Saira | director | Sell | 2,000 | $90.99 | $182.0K | 0Exit |
| Dec 23, 2025 | GREY MICHAEL G | Sell | 50,000 | $78.00 | $3.90M | 0Exit | |
| Dec 23, 2025 | Ramasastry Saira | Sell | 5,000 | $80.00 | $400.0K | 0Exit | |
| Dec 19, 2025 | Ramasastry Saira | Sell | 2,000 | $69.73 | $139.5K | 1,000-67% | |
| Dec 2, 2025 | GREY MICHAEL G | Sell | 50,000 | $74.00 | $3.70M | 0Exit | |
| Nov 25, 2025 | GREY MICHAEL G | Sell | 50,000 | $70.00 | $3.50M | 0Exit | |
| Sep 12, 2025 | Brege Laura | Sell | 17,000 | $74.40 | $1.26M | 17,194-50% | |
| Sep 12, 2025 | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | Sell | 9,578 | $76.01 | $728.0K | 39,945 |
| Aug 12, 2025 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 40,000 | $62.00 | $2.48M | 138,641 |
| Aug 8, 2025 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 10,000 | $58.00 | $580.0K | 2,426-80% |
| Aug 8, 2025 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 40,000 | $55.25 | $2.21M | 138,641 |
| Jul 3, 2025 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 1,041 | $48.63 | $50.6K | 2,903-26% |
| Jun 13, 2025 | Fairey William | Sell | 3,203 | $48.42 | $155.1K | 2,500-56% | |
| Jun 4, 2025 | Ramasastry Saira | Sell | 8,203 | $46.06 | $377.8K | 0Exit | |
| Mar 19, 2025 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 2,415 | $44.45 | $107.3K | 2,426-50% |
| Mar 18, 2025 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 57,606 | $44.35 | $2.55M | 9,436-86% |
| Mar 18, 2025 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 27,279 | $44.21 | $1.21M | 138,641 |
| Mar 18, 2025 | Radovich Peter | PRESIDENT AND COO | Sell | 7,879 | $44.21 | $348.4K | 18,672-30% |
| Mar 5, 2025 | Radovich Peter | PRESIDENT AND COO | Sell | 14,850 | $45.58 | $676.9K | 13,280-53% |
| Mar 4, 2025 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 40,000 | $46.91 | $1.88M | 136,528 |
MIRM Insiders
Similar Stocks to MIRM
VRTX
Vertex Pharmaceuticals Incorporated
$445.21+0.04%
$113.41B
REGN
Regeneron Pharmaceuticals, Inc.
$614.20+0.45%
$65.47B
ALNY
Alnylam Pharmaceuticals, Inc.
$283.35-2.09%
$40.46B
RVMD
Revolution Medicines, Inc.
$153.65+2.96%
$31.73B
UTHR
United Therapeutics Corporation
$542.43-0.54%
$23.12B
INSM
Insmed Incorporated
$98.28+1.64%
$20.41B
INCY
Incyte Corporation
$108.85+0.95%
$20.11B
MRNA
Moderna, Inc.
$50.18+1.06%
$18.89B